Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Hims & Hers Health

Tracked across 7 events · 537 articles · First seen Jun 26, 2025 · Last active Aug 23, 2026

Sentiment
-29
Attention
8
Events
7
Relationships
4
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 -70
Business
Impact: Hims & Hers Health is facing a class action lawsuit for allegedly making false and misleading statements regarding its business practices, specifically the deceptive promotion and selling of 'knockoff' versions of Semaglutide®, which could lead to the termination of its collaboration with Novo Nordisk.
Jul 02, 2025 · 6 articles
6 -70
Regulatory
Impact: Hims & Hers Health dropped its plan to offer a compounded version of Wegovy after the FDA threatened action, leading to a 14% drop in its stock. This decision impacts its strategy in the weight-loss medication market.
Feb 07, 2026 · 6 articles
4 -70
Regulatory
The U.S. United States — Federal Trade Commission (FTC), joined by United States — Utah and United States — Los Angeles County, California, filed a lawsuit against telehealth provider Hims & Hers Health Health on…
Impact: Hims & Hers Health is the defendant, facing allegations of sharing health data and deceptive billing. Its stock fell 12% and it denies the claims.
Jul 29, 2026 · 68 articles
6 20
Business
Impact: Hims & Hers Health launched a cheaper, off-brand version of Semaglutide, capitalizing on the demand for GLP-1 drugs, which led to legal threats from Novo Nordisk.
Feb 05, 2026 · 6 articles
6 10
Business
Impact: Hims & Hers Health is advertising its GLP-1 weight loss drugs, emphasizing access to healthcare, and participating in the health and telehealth advertising trend.
Feb 04, 2026 · 6 articles
8 -20
International
The US-Iran war, ongoing since late February, has severely disrupted global oil markets. The conflict has led to the effective closure of the Strait of Hormuz, a critical chokepoint for about 20% of global oil…
Impact: Hims & Hers Health reported a wider loss, but is not central.
Apr 08, 2026 · 416 articles
4 0
Business
Retail investors sold SpaceX shares on a net basis for the first time since the company's June IPO, offloading $4.5 million on August 7, according to Vanda Research. This reversal follows weeks of persistent net…
Impact: Hims & Hers Health is mentioned as a past Zacks pick, but is not directly related to this event.
Jul 16, 2026 · 29 articles
Novo Nordisk competitor Hims & Hers Health Hims & Hers Health is facing legal threats from Novo Nordisk after their brief d
Novo Nordisk competitor Hims & Hers Health Novo Nordisk terminated its distribution partnership with Hims & Hers Health and
ERGEN INTELLIGENCE
Track Hims & Hers Health live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.